SCHEMBL846863

SCHEMBL846863

N#Cc1ccc(C=CC(=O)Nc2cnc3ccccc3c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.57
MAOA P21397 1/20 0.57
CA12 O43570 4/20 0.53
CA9 Q16790 4/20 0.53
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
USP30 Q70CQ3 1/20 0.51
NAMPT P43490 1/20 0.51
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 1/20 0.50
KDR P35968 1/20 0.49
HDAC2 Q92769 2/20 0.48
RAB9A P51151 6/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846862 1.00 MAOB (0.57) MAOBMAOACA12CA9CA1
SCHEMBL16101601 0.87 KDR (0.60) MAOBMAOANAMPTKDM4EALDH1A1
SCHEMBL13991500 0.87 KDR (0.60) MAOBMAOANAMPTKDM4EALDH1A1
SCHEMBL13991503 0.85 RAB9A (0.65) MAOBMAOANAMPTKDM4EALDH1A1
SCHEMBL846433 0.82 MAOB (0.59) MAOBCA12CA9CA1CA2
SCHEMBL846062 0.82 TRPV1 (0.67) KDM4EMAPTLMNAKDRRAB9A
SCHEMBL846432 0.82 MAOB (0.59) MAOBCA12CA9CA1CA2
SCHEMBL846063 0.82 TRPV1 (0.67) KDM4EMAPTLMNAKDRRAB9A
SCHEMBL846550 0.81 DHODH (0.53) NAMPTKDM4EALDH1A1MAPTLMNA
SCHEMBL846549 0.81 DHODH (0.53) NAMPTKDM4EALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP disclosed
EP-2308848-A1 Quinoline-derived amide modulators of vanilloid VR1 receptor Janssen Pharmaceutica NV (BE) 2011-04-13 EP disclosed